美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=BAL"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
BALANCED SALT 075503 001 ANDA CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE SOLUTION;IRRIGATION 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6.4MG/ML;1.7MG/ML No No 2006/09/27 2006/09/27 EPIC PHARMA LLC Discontinued
BALSALAZIDE DISODIUM 077806 001 ANDA BALSALAZIDE DISODIUM CAPSULE;ORAL 750MG No No 2007/12/28 2007/12/28 HIKMA Prescription
BALSALAZIDE DISODIUM 077807 001 ANDA BALSALAZIDE DISODIUM CAPSULE;ORAL 750MG No No 2007/12/28 2007/12/28 NOVITIUM PHARMA Prescription
BALSALAZIDE DISODIUM 077883 001 ANDA BALSALAZIDE DISODIUM CAPSULE;ORAL 750MG No No 2007/12/28 2007/12/28 APOTEX Prescription
CYMBALTA 022148 001 NDA DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS; ORAL EQ 20MG BASE No No 2008/06/13 -- LILLY Prescription
CYMBALTA 022148 002 NDA DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS; ORAL EQ 30MG BASE No No 2008/06/13 -- LILLY Prescription
CYMBALTA 022148 003 NDA DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS; ORAL EQ 60MG BASE No No 2008/06/13 -- LILLY Prescription
BALANCED SALT 091387 001 ANDA CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM CITRATE SOLUTION;IRRIGATION 0.48MG/ML;0.3MG/ML;0.75MG/ML;3.9MG/ML;6.4MG/ML;1.7MG/ML No No 2010/02/03 2010/02/03 B BRAUN Prescription
CYMBALTA 022516 001 NDA DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS; ORAL EQ 20MG BASE No No 2010/11/04 -- LILLY Prescription
CYMBALTA 022516 002 NDA DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS; ORAL EQ 30MG BASE No No 2010/11/04 -- LILLY Prescription
CYMBALTA 022516 003 NDA DULOXETINE HYDROCHLORIDE CAPSULE, DELAYED REL PELLETS; ORAL EQ 60MG BASE No No 2010/11/04 -- LILLY Prescription
PREGABALIN 091229 001 ANDA PREGABALIN CAPSULE; ORAL 25MG No No 2012/12/31 (TA) -- SANDOZ INC None (Tentative Approval)
PREGABALIN 091229 002 ANDA PREGABALIN CAPSULE; ORAL 50MG No No 2012/12/31 (TA) -- SANDOZ INC None (Tentative Approval)
PREGABALIN 091229 003 ANDA PREGABALIN CAPSULE; ORAL 75MG No No 2012/12/31 (TA) -- SANDOZ INC None (Tentative Approval)
PREGABALIN 091229 004 ANDA PREGABALIN CAPSULE; ORAL 100MG No No 2012/12/31 (TA) -- SANDOZ INC None (Tentative Approval)
PREGABALIN 091229 005 ANDA PREGABALIN CAPSULE; ORAL 150MG No No 2012/12/31 (TA) -- SANDOZ INC None (Tentative Approval)
PREGABALIN 091229 006 ANDA PREGABALIN CAPSULE; ORAL 200MG No No 2012/12/31 (TA) -- SANDOZ INC None (Tentative Approval)
PREGABALIN 091229 007 ANDA PREGABALIN CAPSULE; ORAL 225MG No No 2012/12/31 (TA) -- SANDOZ INC None (Tentative Approval)
PREGABALIN 091229 008 ANDA PREGABALIN CAPSULE; ORAL 300MG No No 2012/12/31 (TA) -- SANDOZ INC None (Tentative Approval)
PREGABALIN 201989 001 ANDA PREGABALIN SOLUTION; ORAL 20MG/ML No No 2013/06/04 (TA) -- LUPIN LTD None (Tentative Approval)
药品名称,活性成分,申请号搜索 高级检索
©2006-2025 DrugFuture->U.S. FDA Drugs Database